Healthcare and Life Science
PhoreMost introduces GlueSEEKER platform for discovery of molecular glue degraders
New drug discovery platform integrates computational approaches with molecular biology for development of novel degrader therapeutics Cambridge, UK, 21 May 2024: PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the next generation of drug targets, announces the introdu...
Deloitte Cambridge opens new business lounge
The Life Sciences Catalyst Business Lounge, designed to be a regional hotspot for start-ups and world-leading businesses in the life sciences sector, has been opened by Deloitte Cambridge. ...
Assessment of the impact of earlier access to disease-modifying treatments with more convenient administration frequency in reducing the socioeconomic burden for multiple sclerosis patients in Europe
The socioeconomic impact of Multiple Sclerosis (MS) extends to various areas of a patient’s life including personal wellbeing and mental health, family life and planning, employment and the lives of caregivers, which is associated with a significant economic and societal burden. Advance...
AT278 ultra-concentrated ultra-rapid acting insulin demonstrates superiority in Phase I Clinical Trial in overweight and obese people with type 2 diabetes
AT278 demonstrates significantly accelerated PK/PD profile compared to NovoRapid® and Humulin® R U-500 in people with Type 2 Diabetes and high BMI ...
ERS Genomics and IRBM sign CRISPR/Cas9 license agreement
License agreement provides IRBM access to CRISPR gene editing technology to be applied across its drug discovery services offering ...
How Meaningful Work Drives Employee Motivation
For many people, the pursuit of purpose and meaning has become a driving force behind employee motivation and engagement. Beyond traditional metrics like salary and benefits, employees are increasingly seeking opportunities to engage in work that aligns with their values and contributes...
New TV series sees surgeon carry out complex facial surgery after e-scooter incident
A leading Addenbrooke’s surgeon performed a complex operation following an e-scooter incident, in a powerful new TV series on treatments to the face, neck and head. ...
Cambridge Science Centre announces AstraZeneca’s valued and continuing support for the coming year
Cambridge Science Centre, a Cambridge-based charity dedicated to fostering curiosity and learning in Science, Technology, Engineering, and Mathematics (STEM) among children, is thrilled to announce the renewal of its partnership with AstraZeneca for the upcoming year. ...
Activotec launches new Activo-Darwin peptide synthesizer
Cambridge, UK, May 4th, 2024: Activotec Ltd announces the launch of its Activo-Darwin Semi-Automated Peptide Synthesizer, a cutting-edge instrument designed for the synthesis of very high quality peptides. The Activo-Darwin is a very affordable, flexible and easy to use tool for ...
Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeutic
Proof-of-Concept study to investigate personalized dose management of first-line anti-hypertensive in improving blood pressure control remotely Key milestone in co-development partnership to combine leading medicine brands with dose optimization technology to advance patient care qu...